The World Health Organization (WHO) has confirmed that more than 25,000 mpox cases have been recorded across Africa in 2024, with over 720 deaths potentially linked to the viral disease.
According to WHO data, the Democratic Republic of Congo (DRC) is the most affected country, with 21,835 recorded cases and 717 fatalities. Across the entire African continent, 25,093 mpox cases have been reported. Laboratory confirmation was received for 5,789 cases, including 32 deaths as of September 8.
Globally, from January 1, 2023, to July 31, 2024, a total of 103,048 confirmed mpox cases were registered in 121 countries, resulting in 229 deaths. The United States recorded the highest number of cases with 33,556, followed by Brazil (11,841), Spain (8,104), and the DRC (4,395). These top 10 countries account for 80% of all mpox cases worldwide.
Despite the removal of the Mpox Global Health Emergency in May 2023, WHO Director-General Dr. Tedros Adhanom Ghebreyesus reinstated the emergency on August 14, 2024, due to the resurgence of the disease in Africa.
Mpox is primarily transmitted in remote areas of central and western Africa, with the first case of animal-to-human transmission recorded in the DRC in 1970. The disease continues to pose a significant public health threat, particularly in areas with limited access to healthcare. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
The İnönü University Turgut Özal Medical Center in Malatya, Türkiye, has once again etched its name in the annals of medical history.
The Turkish Statistical Institute (TurkStat) announced on Wednesday that life expectancy at birth in Türkiye has decreased slightly to 77.3 years for the 2021-2023 period, compared to 77.5 years in the previous period.
The Democratic Republic of the Congo (DRC), the "epicenter" of Africa's ongoing Mpox outbreak, will begin the first phase of its vaccination campaign on October 2, the government announced.